Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CXA-101/tazobactam and metronidazole in complicated intra-abdominal infections
NCT01147640Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Jun 2010
- Primary completion
- Feb 2011
- Countries
- 5
01
Overview
Phase 2, randomised, double-blind trial in Intra-abdominal infection (IAI) comparing CXA-101/tazobactam + metronidazole with meropenem + saline placebo (2 arms). Primary endpoint: Clinical Response at Test of Cure. Started Jun 2010; status: completed.
02
Drugs
ceftolozane + tazobactam
03
Conditions
Intra-abdominal infection (IAI)
Beyond the preview
Go deeper on NCT01147640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01147640.